CD4 and neoplasm: Using bioluminescence imaging to measure tumor burden, we have observed similar results with these two tumor doses showing that GzmB−/− CD4+CD25− Tcon cells are less effective than WT CD4+CD25− Tcon cells in controlling tumor growth (Figure 1C–1D).